Shanghai ZJ Bio-Tech Co (SHSE:688317) Retained Earnings: ¥1,287.4 Mil (As of Mar. 2026)


SHSE:688317 Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
64 GF Score
Price ¥15.34
GF Value ¥9.87
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shanghai ZJ Bio-Tech Co Retained Earnings?

Shanghai ZJ Bio-Tech Co SHSE:688317 -2.04% 64 Retained Earnings is ¥1,287.4 Mil as of Mar. 2026. GuruFocus rates SHSE:688317 with a GF Score™ of 64/100 and a GF Value™ of ¥9.87 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Shanghai ZJ Bio-Tech Co's retained earnings for the quarter that ended in Mar. 2026 was ¥1,287.4 Mil.

Shanghai ZJ Bio-Tech Co's quarterly retained earnings declined from Sep. 2025 (¥1,317.9 Mil) to Dec. 2025 (¥1,312.9 Mil) and declined from Dec. 2025 (¥1,312.9 Mil) to Mar. 2026 (¥1,287.4 Mil).

Shanghai ZJ Bio-Tech Co's annual retained earnings declined from Dec. 2023 (¥1,489.2 Mil) to Dec. 2024 (¥1,340.9 Mil) and declined from Dec. 2024 (¥1,340.9 Mil) to Dec. 2025 (¥1,312.9 Mil).


Shanghai ZJ Bio-Tech Co  (SHSE:688317) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Shanghai ZJ Bio-Tech Co Retained Earnings Historical Data

* Premium members only.

The historical data trend for Shanghai ZJ Bio-Tech Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai ZJ Bio-Tech Co Retained Earnings Chart

Shanghai ZJ Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,360.81 1,855.47 1,489.23 1,340.89 1,312.95

Shanghai ZJ Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,324.87 1,331.04 1,317.87 1,312.95 1,287.44
SHSE:688317
64GF Score
Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai ZJ Bio-Tech Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of ¥1,287.4 Mil mean?
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Retained Earnings of ¥1,287.4 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shanghai ZJ Bio-Tech Co and its competitors.
Is Shanghai ZJ Bio-Tech Co's Retained Earnings too high?
Shanghai ZJ Bio-Tech Co's current Retained Earnings is ¥1,287.4 Mil. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Retained Earnings compare to ABT and SYK?
Shanghai ZJ Bio-Tech Co's Retained Earnings of ¥1,287.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. Shanghai ZJ Bio-Tech Co's current Retained Earnings is ¥1,287.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.87, compared to a current price of ¥15.34 — trading 55.4% above its estimated fair value. The current Retained Earnings is ¥1,287.4 Mil. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 64/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Retained Earnings is ¥1,287.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued. The current stock price of ¥15.34 is trading 55.4% above its estimated GF Value™ of ¥9.87. GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.

Key valuation signals for SHSE:688317:

  • Retained Earnings: ¥1,287.4 Mil
  • GF Value™: ¥9.87 vs. price of ¥15.34 (55.4% above fair value)
  • GF Score™: 64/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai ZJ Bio-Tech Co Business Description

Address No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
64GF Score

Get the complete analysis for SHSE:688317

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.34
Price
¥9.87
GF Value